Search

everythinglearnresearchcommunity

for

Search:↓

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Modified Changfa Zirong Powder improves hair growth in androgenetic alopecia.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

High androgen levels cause skin issues in PCOS, affecting quality of life.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Hirsutism, often caused by PCOS, is treated with medication and weight loss is important for obese women with PCOS.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Low androgen levels can still cause female pattern hair loss.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Higher testosterone levels in Nigerian women with PCOS are linked to glucose disorders like diabetes.

More personalized and effective treatments for androgenetic alopecia are needed.

Oestrogen does not affect adrenal androgen levels in children and adolescents.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

More plasma leptin means higher baldness risk in men.